Tim J. Crook

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma.

Inhibition of the angiotensin II type 2 receptor AT2R is a novel therapeutic strategy for glioblastoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 02, 2022

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.

Fesoterodine treatment of pediatric patients with neurogenic detrusor overactivity: A 24-week, randomized, open-label, phase 3 study.

Journal: Journal of pediatric urology

Published: July 28, 2022

Encapsulation of Small Drugs in a Supramolecule Enhances Solubility, Stability, and Therapeutic Efficacy Against Glioblastoma Multiforme.

Encapsulation of Small Drugs in a Supramolecule Enhances Solubility, Stability, and Therapeutic Efficacy Against Glioblastoma Multiforme.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 28, 2020

Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.

Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.

Journal: Free radical biology & medicine

Published: June 22, 2020

Expression and subcellular localization of the bromodomain-containing protein 7 is a prognostic biomarker in breast cancer.

Expression and subcellular localization of the bromodomain-containing protein 7 is a prognostic biomarker in breast cancer.

Journal: Anti-cancer drugs

Published: January 14, 2020

Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients.

Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients.

Journal: Journal of pharmaceutical and biomedical analysis

Published: September 08, 2018

DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer.

DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer.

Journal: Annals of translational medicine

Published: August 11, 2018

Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.

Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.

Journal: Journal of pharmaceutical and biomedical analysis

Published: July 06, 2018

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.

Journal: Cell death & disease

Published: July 02, 2018

The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention.

The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention.

Journal: Oncogene

Published: May 28, 2018

Correction to: Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

Correction to: Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.

Journal: BMC cancer

Published: February 13, 2018

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.

Journal: The Journal of investigative dermatology

Published: September 16, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026